These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8702500)

  • 1. Immunosuppressant target protein FKBP12 is required for P-glycoprotein function in yeast.
    Hemenway CS; Heitman J
    J Biol Chem; 1996 Aug; 271(31):18527-34. PubMed ID: 8702500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targets of immunophilin-immunosuppressant complexes are distinct highly conserved regions of calcineurin A.
    Cardenas ME; Muir RS; Breuder T; Heitman J
    EMBO J; 1995 Jun; 14(12):2772-83. PubMed ID: 7540976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcineurin-dependent growth of an FK506- and CsA-hypersensitive mutant of Saccharomyces cerevisiae.
    Parent SA; Nielsen JB; Morin N; Chrebet G; Ramadan N; Dahl AM; Hsu MJ; Bostian KA; Foor F
    J Gen Microbiol; 1993 Dec; 139(12):2973-84. PubMed ID: 7510323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin.
    Bell A; Wernli B; Franklin RM
    Biochem Pharmacol; 1994 Aug; 48(3):495-503. PubMed ID: 7520696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophilins interact with calcineurin in the absence of exogenous immunosuppressive ligands.
    Cardenas ME; Hemenway C; Muir RS; Ye R; Fiorentino D; Heitman J
    EMBO J; 1994 Dec; 13(24):5944-57. PubMed ID: 7529175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myristoylation of calcineurin B is not required for function or interaction with immunophilin-immunosuppressant complexes in the yeast Saccharomyces cerevisiae.
    Zhu D; Cardenas ME; Heitman J
    J Biol Chem; 1995 Oct; 270(42):24831-8. PubMed ID: 7559604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcineurin is essential in cyclosporin A- and FK506-sensitive yeast strains.
    Breuder T; Hemenway CS; Movva NR; Cardenas ME; Heitman J
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5372-6. PubMed ID: 7515500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin A, FK506 and rapamycin: more than just immunosuppression.
    Kunz J; Hall MN
    Trends Biochem Sci; 1993 Sep; 18(9):334-8. PubMed ID: 7694398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action.
    Bierer BE
    Chem Immunol; 1994; 59():128-55. PubMed ID: 7524531
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of cyclosporin A and FK506 on Fc epsilon receptor type I-initiated increases in cytokine mRNA in mouse bone marrow-derived progenitor mast cells: resistance to FK506 is associated with a deficiency in FK506-binding protein FKBP12.
    Kaye RE; Fruman DA; Bierer BE; Albers MW; Zydowsky LD; Ho SI; Jin YJ; Castells MC; Schreiber SL; Walsh CT
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8542-6. PubMed ID: 1382293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional expression of P-glycoprotein in Saccharomyces cerevisiae confers cellular resistance to the immunosuppressive and antifungal agent FK520.
    Raymond M; Ruetz S; Thomas DY; Gros P
    Mol Cell Biol; 1994 Jan; 14(1):277-86. PubMed ID: 7505392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations that perturb cyclophilin A ligand binding pocket confer cyclosporin A resistance in Saccharomyces cerevisiae.
    Cardenas ME; Lim E; Heitman J
    J Biol Chem; 1995 Sep; 270(36):20997-1002. PubMed ID: 7673124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel FK506 binding protein can mediate the immunosuppressive effects of FK506 and is associated with the cardiac ryanodine receptor.
    Lam E; Martin MM; Timerman AP; Sabers C; Fleischer S; Lukas T; Abraham RT; O'Keefe SJ; O'Neill EA; Wiederrecht GJ
    J Biol Chem; 1995 Nov; 270(44):26511-22. PubMed ID: 7592869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrotoxicity of immunosuppressants in rats: comparison of macrolides with cyclosporin.
    Ryffel B; Weber E; Mihatsch MJ
    Exp Nephrol; 1994; 2(6):324-33. PubMed ID: 7532090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal effects of cyclosporine and FK 506 are mediated via immunophilin-dependent calcineurin inhibition.
    Heitman J; Cardenas ME; Breuder T; Hemenway C; Muir RS; Lim E; Goetz L; Zhu D; Lorenz M; Dolinski K
    Transplant Proc; 1994 Oct; 26(5):2833-4. PubMed ID: 7524220
    [No Abstract]   [Full Text] [Related]  

  • 16. The complex of FK506-binding protein 12 and FK506 inhibits calcineurin phosphatase activity and IgE activation-induced cytokine transcripts, but not exocytosis, in mouse mast cells.
    Fruman DA; Bierer BE; Benes JE; Burakoff SJ; Austen KF; Katz HR
    J Immunol; 1995 Feb; 154(4):1846-51. PubMed ID: 7530743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin.
    Cardenas ME; Zhu D; Heitman J
    Curr Opin Nephrol Hypertens; 1995 Nov; 4(6):472-7. PubMed ID: 8591053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of ternary immunophilin-calcineurin complexes with the immunosuppressants cyclosporin and macrolide FK506.
    Woerly G; Weber E; Ryffel B
    Biochem Pharmacol; 1994 Apr; 47(8):1435-43. PubMed ID: 7514409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional structure and actions of immunosuppressants and their immunophilins.
    Braun W; Kallen J; Mikol V; Walkinshaw MD; Wüthrich K
    FASEB J; 1995 Jan; 9(1):63-72. PubMed ID: 7529736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biology of cyclosporin A and FK506.
    Bierer BE
    Prog Clin Biol Res; 1994; 390():203-23. PubMed ID: 7536944
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.